raltitrexed
Selected indexed studies
- Raltitrexed in mesothelioma. (Expert Rev Anticancer Ther, 2011) [PMID:21999120]
- Raltitrexed-based chemotherapy for advanced colorectal cancer. (Clin Res Hepatol Gastroenterol, 2014) [PMID:24388340]
- Raltitrexed: optimism and reality. (Expert Opin Drug Metab Toxicol, 2009) [PMID:19863453]
_Worker-drafted node — pending editorial review._
Connections
raltitrexed is a side effect of
Sources
- Raltitrexed in mesothelioma. (2011) pubmed
- Raltitrexed-based chemotherapy for advanced colorectal cancer. (2014) pubmed
- Raltitrexed: optimism and reality. (2009) pubmed
- Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. (2013) pubmed
- Raltitrexed: current clinical status and future directions. (2002) pubmed
- Raltitrexed in colorectal cancer. (1996) pubmed
- SALIRI-based (raltitrexed plus irinotecan) therapy as a second-line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non-interventional, registry study. (2024) pubmed
- Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy. (2001) pubmed
- Apatinib plus hepatic arterial infusion of oxaliplatin and raltitrexed for hepatocellular carcinoma with extrahepatic metastasis: phase II trial. (2024) pubmed
- Clinical and preclinical pharmacokinetics of raltitrexed. (2000) pubmed